Insights
Scientific Research
Real-World Data Analysis of First-Line Third-Generation EGFR Tyrosine Kinase Inhibitor (EGFR-TKI) Compared to Clinical Trials Using Danny Platform
July 2025, Expert Review of Pharmacoeconomics & Outcomes Research, an esteemed peer-reviewed journal published by Taylor & Francis Group, released the article titled “Real-world evidence of first-line Osimertinib...
Scientific Research
Real-World Data Analysis of BRAF-Targeted Melanoma Therapy Compared to Clinical Trials Using Danny Platform
December 2024, Pharmacia, a multidisciplinary journal for pharmaceutical and allied sciences, has published the research article, “Real-world effectiveness of dabrafenib and trametinib in patients with...
Scientific Research
Real-World Data Analysis of Adult Heart Failure Patients Using Danny Platform
October 2024, Acta Medica Bulgaria—the leading peer-reviewed, open-access medical journal of the Medical University Sofia published "Describing Adult Heart Failure Patients – Assessment of Real-Life...